The risks and benefits of generative AI in healthcare: The AI craze is triggering mixed feelings in healthcare communities as tech players continue to tout their tools for healthcare tasks.
The FTC strikes healthcare again: The federal regulatory agency issued 670 warnings to healthcare companies and others about misleading advertising. Healthcare firms: be ready to back up your claims.
Digital health startups to watch: This week, we spotlight virtual GI clinic Oshi Health and clinical workflow tech vendor Florence on the back of fresh funding.
Walgreens, Prothena team up for Alzheimer’s clinical trial: We detail why pharma companies and retailers are a natural fit to improve clinical trial participation and retention.
Big Pharma needs a better local online presence: We dive into the 2023 Worldcom Digital Health Monitor report to find out which of the largest pharma companies are winning and who’s losing opportunities based on their online presence.
Digital health companies are facing days of reckoning: Financial pressures are forcing bankruptcies, layoffs, and strategic pivots. It’s going to get worse before it gets better.
Investors see opportunities in VBC players: But they’ll have to play the long game to achieve financial success. VBC models don’t produce results overnight.
ChatGPT makes smart glasses even smarter, maybe: Innovative Eyewear’s new Lucyd app lets you talk to the AI chatbot through your eyeglasses, even while driving.
On today's episode, we discuss early initiatives to integrate generative AI into healthcare, the ways in which ChatGPT in healthcare could become a huge liability, and how chatbots can boost patient engagement. "In Other News," we talk about how to turn bad reviews into positive change and how ChristianaCare's subscription primary care offering is a little bit different. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
The new patient engagement player on the block: WellSky Patient is the latest addition in the home health management space. Its focus on home care is its key differentiator.
Consumers see pharmacists as a go-to healthcare source: Pharmacists’ roles and responsibilities evolved during the pandemic. Patients are noticing—and trusting them more than ever.
Biased data is bad data: A JAMA study found demographic and socioeconomic factors significantly affected wearable device research.
Digital health startups to watch: This week, we spotlight value-based care enabler Wellvana Health and patient engagement company Wellth on the back of fresh funding.
Latino patients could score cheaper Rx: Zócalo Health, a virtual care provider serving Latinos, is partnering with Mark Cuban Cost Plus Drug Company. The upshot could be big cost savings for consumers.
Quality of care doesn’t beat real revenue: A new AMN Healthcare report on physicians’ bills highlights how healthcare stakeholders’ revenue goals are misaligned.
So far this year, there’s been Google versus Microsoft and TikTok versus … well, everyone. But another battle is emerging as Amazon and Apple go head to head for ad dollars, streaming viewers, and the health vertical.
Mozarc Medical joins the kidney care market: The field of kidney care startups has seen strong growth in the past year. Can that continue?
Digital health startups face a rocky 2023: We unpack the implications of Rock Health’s Q1 2023 funding report.
RPM adoption surges, but faces future roadblocks: We unpack recent trends on remote patient monitoring usage among doctors and factors preventing further growth.
Consumers are increasingly becoming more comfortable with technology, and the usage of health apps and wearables is becoming more prevalent. Explore how consumers are using technology to monitor their health and wellness, and learn more about the market potential.